- Bend Bulletin main site
- Bend Bulletin archives
- Terms of Use
- Privacy Policy
- Contact the Bulletin
- Comments/Questions?
Published daily in Bend, Oregon, by Western Communications, Inc. Copyright 2007.
August 1, 2008
TRENTON, N.J. — Bristol- Myers Squibb Co. on Thursday offered $4.5 billion in cash for its cancer drug partner, biotechnology company ImClone Systems Inc., saying the two are “a natural fit.”
The proposal offers ImClone stockholders $60 per share, a 30 percent....